Table 3.
Laboratory measures
| T0 | T6 | Δ T0–T6 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| All patients | N | C | All patients | N | C | All patients | N | C | |
| HB, g/dl, mean ± SD | 14.3 ± 1.3 | 14.3 ± 1.1 | 14.2 ± 1.4 | 14.4 ± 1.2 | 14.4 ± 1.1 | 14.4 ± 1.3 | 0.1 ± 0.9 | 0.1 ± 1 | 0.1 ± 0.8 |
| WBC, 1/mm3, mean ± SD | 6684.6 ± 1809.9 | 6681.9 ± 1722.3 | 6731.4 ± 1885 | 6911.2 ± 1750.7 | 6649.6 ± 1512.8 | 7106.3 ± 1897.3 | 226.5 ± 1505.4 | 227.7 ± 1347.8 | 374.9 ± 1607.5 |
| PLT, 103/mm3, mean ± SD | 267.5 ± 229.1 | 241.5 ± 59.2 | 287 ± 298 | 247.5 ± 65.2 | 239.2 ± 60.5 | 253.6 ± 68.2 | −20.1 ± 225.5 | −12.3 ± 34.4 | −33.4 ± 296.8 |
| CRP, mg/L, mean ± SD | 3.4 ± 6.2 | 3.2 ± 3.9 | 3.7 ± 7.4 | 3.5 ± 5.6 | 2.6 ± 3.1 | 4.1 ± 6.9 | 0.1 ± 6.4 | −0.1 ± 4 | 0.3 ± 7.7 |
| ESR, mm/h, mean ± SD | 15.2 ± 17.1 | 13.8 ± 14.4 | 16.3 ± 18.9 | 14.1 ± 13.6 | 11.6 ± 10.3 | 16 ± 15.5 | −1.1 ± 13.1 | −2.2 ± 9.7 | −0.3 ± 15.2 |
| Urate, mg/dl, mean ± SD | 5.5 ± 1.1 | 5.4 ± 1 | 5.6 ± 1.3 | 4.8 ± 1.8 | 4.7 ± 2 | 4.9 ± 1.7 | −0.5 ± 1.6 | −0.1 ± 0.3 | −0.7 ± 1.9 |
| HbA1c, mmol/mol, mean ± SD*** | 47.4 ± 15 | 52.5 ± 21.1 | 44 ± 9 | 59.6 ± 20.7 | 63.2 ± 26.1 | 57.7 ± 18.5 | 4.5 ± 13.3 | 7.3 ± 21.5 | 2.7 ± 5.6 |
| FBG, mg/dl, mean ± SD* | 105.1 ± 26.5 | 113.3 ± 30.4 | 100.9 ± 23.8 | 101.6 ± 27.2 | 98.9 ± 25 | 103.5 ± 28.9 | 2.4 ± 21.4 | −7.4 ± 14.7 | 7.3 ± 22.9 |
| LDL-c, mg/dl, mean ± SD | 130.8 ± 36.5 | 132.3 ± 35 | 129.7 ± 38.4 | 130.6 ± 34.7 | 125.7 ± 34.8 | 134.4 ± 34.5 | −1.2 ± 24.1 | −5.2 ± 31.6 | 1.8 ± 16.7 |
| HDL-c, mg/dl, mean ± SD** | 54.7 ± 15.4 | 61.1 ± 17.5 | 49.8 ± 11.7 | 55.7 ± 17.5 | 59.2 ± 21.2 | 53 ± 13.6 | 0 ± 8 | −1.1 ± 7.3 | 0.9 ± 8.5 |
| TC, mg/dl, mean ± SD | 209.7 ± 45.1 | 211.4 ± 41.2 | 208.5 ± 48.4 | 205.6 ± 37.2 | 204.9 ± 40.6 | 206.2 ± 34.6 | 2.1 ± 26 | −0.1 ± 29.5 | 3.8 ± 23.3 |
| Triglycerides, mg/dl, mean ± SD | 123.2 ± 63.4 | 118.8 ± 57.3 | 127.4 ± 65.7 | 125.3 ± 57.8 | 115.5 ± 52.5 | 130.8 ± 60.6 | 2.5 ± 44 | −3.3 ± 51.1 | 3.8 ± 38.1 |
| TC/HDL-c ratio, mean ± SD | 4 ± 1.4 | 3.8 ± 1.3 | 4.2 ± 1.4 | 4.1 ± 1.4 | 3.9 ± 1.3 | 4.3 ± 1.5 | 0.1 ± 0.5 | 0 ± 0.6 | 0.1 ± 0.4 |
| GOT, U/L, mean ± SD | 22.4 ± 8.7 | 23.1 ± 9.1 | 21.8 ± 8.5 | 23.1 ± 8.2 | 23.5 ± 8.6 | 22.9 ± 8 | 0.8 ± 8 | 0.4 ± 7.9 | 1 ± 8.2 |
| GPT, U/L, mean ± SD | 24.4 ± 15 | 24.7 ± 15.2 | 24.3 ± 15 | 25.1 ± 13.6 | 25.1 ± 12.6 | 25.1 ± 14.4 | 0.7 ± 13.1 | 0.4 ± 11.3 | 0.9 ± 14.3 |
| GGT, U/L, mean ± SD | 21.8 ± 19.1 | 23.7 ± 20.3 | 20.5 ± 18.1 | 23.5 ± 19.7 | 24.6 ± 23.4 | 22.7 ± 16.5 | 1.7 ± 20.2 | 1 ± 16.6 | 2.2 ± 22.5 |
| Creatinine, mg/dl, mean ± SD | 0.9 ± 0.2 | 0.9 ± 0.3 | 0.9 ± 0.2 | 1 ± 1.4 | 1.2 ± 2.1 | 0.8 ± 0.2 | 0.1 ± 1.3 | 0.3 ± 2 | 0 ± 0.1 |
| TSH, μU/ml, mean ± SD | 3.2 ± 2 | 2.9 ± 0.5 | 3.3 ± 2 | 3.5 ± 2.6 | 3.6 ± 3.6 | 3.4 ± 1.9 | 0.3w ± 3.7 | 0.5 ± 6.4 | 0.2 ± 0.4 |
N nutritional group, C control group, HB hemoglobin, WBC white blood count, PLT platelets, ESR erythrocyte sedimentation rate, CRP C-reactive protein, HbA1c glycated hemoglobin, FBG fasting blood glucose, LDL-c low-density lipoprotein cholesterol, HDL-c high-density lipoprotein cholesterol, TC total cholesterol, GOT glutamic oxaloacetic transaminase, GPT glutamic pyruvic transaminase, GGT gamma-glutamyltransferase, TSH thyroid-stimulating hormone
*A significative difference in the FBG levels was observed at T0 comparing the N and C (p = 0.039)
**A significative difference in the HDL-c levels was observed at T0 comparing the N and C (p = 0.048)
***A significative change in HbA1c was observed at T6 in the N compared to C (p = 0.01)